Clearance of Recalcitrant Verruca Plana Following COVID-19 Vaccination
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Reche P
. Potential Cross-Reactive Immunity to SARS-CoV-2 From Common Human Pathogens and Vaccines. Front Immunol. 2020; 11:586984.
PMC: 7596387.
DOI: 10.3389/fimmu.2020.586984.
View
2.
Gonzalez-Perez M, Sanchez-Tarjuelo R, Shor B, Nistal-Villan E, Ochando J
. The BCG Vaccine for COVID-19: First Verdict and Future Directions. Front Immunol. 2021; 12:632478.
PMC: 7982405.
DOI: 10.3389/fimmu.2021.632478.
View
3.
Soodejani M, Basti M, Tabatabaei S, Rajabkhah K
. Measles, mumps, and rubella (MMR) vaccine and COVID-19: a systematic review. Int J Mol Epidemiol Genet. 2021; 12(3):35-39.
PMC: 8310886.
View
4.
Demirbas A, Eker H, Elmas O, Demirbas G, Atasoy M, Tursen U
. COVID-19 and human papillomavirus: Paradoxical immunity. J Cosmet Dermatol. 2021; 20(7):2001-2003.
PMC: 8014313.
DOI: 10.1111/jocd.14022.
View
5.
Erkayman M, Bilen H
. Clearance of longstanding treatment-resistant warts during COVID-19 in a transplant recipient. Transpl Infect Dis. 2021; 23(4):e13572.
PMC: 7994983.
DOI: 10.1111/tid.13572.
View